HomeOTLK • NASDAQ
add
Outlook Therapeutics Inc
Previous close
$2.18
Day range
$2.14 - $2.37
Year range
$0.87 - $12.85
Market cap
56.06M USD
Avg Volume
3.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.35M | 37.78% |
Net income | 5.69M | 143.81% |
Net profit margin | — | — |
Earnings per share | -0.94 | -0.10% |
EBITDA | -22.85M | -83.56% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.93M | -36.19% |
Total assets | 28.82M | -10.77% |
Total liabilities | 101.90M | 118.02% |
Total equity | -73.08M | — |
Shares outstanding | 24.91M | — |
Price to book | -0.71 | — |
Return on assets | -150.68% | — |
Return on capital | 121.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 5.69M | 143.81% |
Cash from operations | -16.98M | -33.28% |
Cash from investing | — | — |
Cash from financing | -114.95K | -104.74% |
Net change in cash | -17.10M | -65.71% |
Free cash flow | -8.79M | -1.26% |
About
Founded
2010
Website
Employees
23
